Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer's Asia Head of R&D Leaves for AstraZeneca
Seeking Alpha
Monday, December 13, 2010 - 8:31pm
tags:
Pfizer, Asia, R&D, AstraZeneca
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Monday, December 13, 2010 - 12:26pm
tags:
MannKind, Afrezza, Alimera, pSivida, Seattle Genetics, brentuximab vedotin, Illuvien, AstraZeneca, Zictifa, Clinical Data, Vilazodone, Orexigen, Contrave, Bristol-Myers Squibb, Yervoy, Pfizer, Protalix BioTherapeutics, UPLYSO, Xiafaxan, Salix, Human Genome Sciences, Benlysta, Dendreon, Provenge, InterMune, Esbriet, Cell Therapeutics, pixantrone, Forest Labs, Daxas, MELA Sciences, MelaFind, XenoPort, GSK, Horizant, Spectrum Pharmaceuticals, Fusilev, Adventrx, Vertex Pharmaceuticals, Telaprevir
Inspire Pharmaceuticals launches drug in Japan
Bizjournals.com
Monday, December 13, 2010 - 12:18pm
tags:
Inspire, Japan, dry eye disease, Diquas
Nektar slides after deciding against partnership
Yahoo/AP
Monday, December 13, 2010 - 12:17pm
tags:
Nektar, cancer
US top court to decide generic drug labeling issue
Reuters
Monday, December 13, 2010 - 11:40am
tags:
generics, Supreme Court, Teva Pharmaceuticals, Mylan, Actavis
Sequenom Insider Trading Case Describes a Nest of Leaks and Incompetence
BNET Pharma
Monday, December 13, 2010 - 11:37am
tags:
insider trading, Sequenom
GlaxoSmithKline to buy Maxinitrition in $255M deal
Bizjournals.com
Monday, December 13, 2010 - 11:36am
tags:
GSK, M&S, Maxinitrition
Sanofi and Genzyme: Time for a Compromise?
WSJ Online
Monday, December 13, 2010 - 11:35am
tags:
M&A, Sanofi, Genzyme
Amgen, Actelion Talk but No Offer Made
TheStreet.com
Monday, December 13, 2010 - 10:13am
tags:
Amgen, Actelion, M&A
Sanofi extends deadline for Genzyme offer
Marketwatch
Monday, December 13, 2010 - 10:11am
tags:
Genzyme, Sanofi, M&A
Dr. Reddy's: An Indian Stock for the Future
Seeking Alpha
Monday, December 13, 2010 - 10:10am
tags:
Dr Reddy's
Galderma Said to Agree to Buy Q-Med to Gain Smoother
Bloomberg
Monday, December 13, 2010 - 10:09am
tags:
Q-Med, Galderma, M&A
Cephalon Stem Cell Deal Catches Analysts Off-Guard
Seeking Alpha
Monday, December 13, 2010 - 10:08am
tags:
stem cells, Cephalon, Mesoblast
Analysts Welcome Change at Pfizer’s Helm but Want More
Seeking Alpha
Monday, December 13, 2010 - 10:07am
tags:
Pfizer, Ian Read, analysts
How Cheap Is Merck's Stock by the Numbers?
Motley Fool
Monday, December 13, 2010 - 10:06am
tags:
Merck
Is Eli Lilly's Stock Cheap by the Numbers?
Motley Fool
Monday, December 13, 2010 - 10:05am
tags:
Eli Lilly
Sanofi-Aventis (NYSE: SNY) Upgraded by Zacks Investment Research to “Outperform”
American Banking Market News
Saturday, December 11, 2010 - 1:01pm
tags:
Sanofi, investors
Avanir Pharmaceuticals Chart Point to Possible Trend Reversal
Wall Street Newscast
Saturday, December 11, 2010 - 12:59pm
tags:
Avanir, investors
Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
PR-USA
Saturday, December 11, 2010 - 12:57pm
tags:
Afatinib, breast cancer, Boehringer Ingelheim
Pfizer tops the list as big pharma turns to acquisitions as its preferred growth track
The Day, CT
Saturday, December 11, 2010 - 12:56pm
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.